Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

NCT00183976 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Insufficient Accrual

Conditions

Non-Hodgkin's Lymphoma
Burkitt Lymphoma
Primary Effusion Lymphomas

Interventions

DRUG: Pegylated Liposomal Doxorubicin (Doxil) and Rituximab

Sponsor

University of Southern California